Illumina Company Profile (NASDAQ:ILMN)

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NASDAQ:ILMN
  • CUSIP: 45232710
  • Web: www.illumina.com
Capitalization:
  • Market Cap: $29.24 billion
  • Outstanding Shares: 146,000,000
Average Prices:
  • 50 Day Moving Avg: $199.76
  • 200 Day Moving Avg: $181.17
  • 52 Week Range: $119.37 - $214.34
P/E:
  • Trailing P/E Ratio: 40.270
  • Foreward P/E Ratio: 45.41
  • P/E Growth: 3.760
Sales & Book Value:
  • Annual Revenue: $2.49 billion
  • Price / Sales: 11.74
  • Book Value: $18.60 per share
  • Price / Book: 10.77
Profitability:
  • EBIDTA: $666.78 million
  • Net Margins: 30.27%
  • Return on Equity: 19.69%
  • Return on Assets: 10.81%
Debt:
  • Debt-to-Equity Ratio: 0.43%
  • Current Ratio: 3.88%
  • Quick Ratio: 3.42%
Misc:
  • Average Volume: 939,606 shs.
  • Beta: 0.81
  • Short Ratio: 4.8
 

Frequently Asked Questions for Illumina (NASDAQ:ILMN)

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) issued its quarterly earnings results on Tuesday, August, 1st. The company reported $0.82 EPS for the quarter, beating the Zacks' consensus estimate of $0.68 by $0.14. The business had revenue of $662 million for the quarter, compared to analysts' expectations of $642.38 million. Illumina had a net margin of 30.27% and a return on equity of 19.69%. The business's quarterly revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.86 earnings per share. View Illumina's Earnings History.

What guidance has Illumina issued on next quarter's earnings?

Illumina updated its FY17 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of $3.60-3.70 for the period, compared to the Thomson Reuters consensus estimate of $3.63. The company issued revenue guidance of +12% to ~$2.69 billion, compared to the consensus revenue estimate of $2.66 billion.

Where is Illumina's stock going? Where will Illumina's stock price be in 2017?

19 brokers have issued twelve-month price objectives for Illumina's stock. Their forecasts range from $122.00 to $250.00. On average, they anticipate Illumina's share price to reach $179.15 in the next twelve months. View Analyst Ratings for Illumina.

What are analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

  • 1. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)
  • 2. According to Zacks Investment Research, "Illumina exited the second quarter on a solid note, with both earnings and revenues beating the Zacks Consensus Estimate. The top line was strong on new product launches including the VeriSeq NIPT Solution in Europe and the strength in NovaSeq. Outside the U.S., the rate of NIPT adoption is increasing. In this regard to note, over the last three months, Illumina was trading above the broader industry. The company’s raised guidance is encouraging indicating this bullish trend to continue in the coming period. We are currently looking forward to the performance of the Extended RAS Panel that is slated for launch in the third quarter. We are also looking forward to GRAIL, Illumina’s venture in the cancer screening market. On the flip side, weak margins owing to NovaSeq launch, higher array services revenues and product mix within sequencing consumables will continue to act as deterrents. Also, NIH funding issue and a tough competitive landscap" (8/4/2017)

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

  • Jay T. Flatley, Executive Chairman of the Board
  • Francis A. deSouza, President, Chief Executive Officer, Director
  • Sam Samad, Chief Financial Officer, Senior Vice President
  • Marc A. Stapley, Executive Vice President, Chief Administrative Officer
  • Garret Hampton Ph.D., Executive Vice President - Clinical Genomics
  • Omead Ostadan, Executive Vice President - Operations, Products and Strategy
  • Mostafa Ronaghi Ph.D., Chief Technology Officer, Senior Vice President
  • Charles E. Dadswell, Senior Vice President, General Counsel, Secretary
  • Mark Van Oene, Senior Vice President, Chief Commercial Officer
  • Arthur Blaine Bowman, Lead Independent Director

Who owns Illumina stock?

Illumina's stock is owned by a number of of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (12.80%), Capital Research Global Investors (8.91%), Vanguard Group Inc. (6.78%), Jennison Associates LLC (3.18%), Capital World Investors (1.46%) and TIAA CREF Investment Management LLC (1.01%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Oene Mark Van, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including Bessemer Group Inc., Aviva PLC, Capital Research Global Investors, Jennison Associates LLC, FMR LLC, Baillie Gifford & Co., FIL Ltd and APG Asset Management N.V.. Company insiders that have sold Illumina stock in the last year include A Blaine Bowman, Charles Dadswell, Daniel Bradbury, Frances Arnold, Jay T Flatley, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van and Omead Ostadan. View Insider Buying and Selling for Illumina.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was bought by a variety of institutional investors in the last quarter, including Winslow Capital Management LLC, HPM Partners LLC, Fred Alger Management Inc., TIAA CREF Investment Management LLC, Capital World Investors, American Century Companies Inc., Janus Henderson Group PLC and Renaissance Technologies LLC. View Insider Buying and Selling for Illumina.

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of Illumina stock can currently be purchased for approximately $200.24.


MarketBeat Community Rating for Illumina (NASDAQ ILMN)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  660 (Vote Outperform)
Underperform Votes:  648 (Vote Underperform)
Total Votes:  1,308
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Illumina (NASDAQ:ILMN) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 9 Buy Ratings
Consensus Rating:Hold (Score: 2.37)
Consensus Price Target: $179.15 (10.53% downside)

Analysts' Ratings History for Illumina (NASDAQ:ILMN)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/13/2017ArgusBoost Price TargetBuy$205.00 -> $235.00LowView Rating Details
9/12/2017Leerink SwannReiterated RatingOutperform$207.00 -> $225.00LowView Rating Details
8/9/2017Barclays PLCReiterated RatingEqual Weight$150.00LowView Rating Details
8/7/2017Canaccord GenuityUpgradeHold -> Buy$170.00 -> $215.00MediumView Rating Details
8/2/2017Cowen and CompanyReiterated RatingOutperform$200.00HighView Rating Details
8/2/2017J P Morgan Chase & CoReiterated RatingOverweight$250.00HighView Rating Details
8/2/2017First AnalysisUpgradeUnderweight -> Equal Weight$176.00HighView Rating Details
7/28/2017Deutsche Bank AGSet Price TargetHold$175.00LowView Rating Details
7/10/2017Morgan StanleyReiterated RatingUnderweight$115.00 -> $122.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$155.00 -> $170.00HighView Rating Details
4/14/2017Piper Jaffray CompaniesReiterated RatingOverweight$170.00 -> $187.00N/AView Rating Details
4/11/2017Bank of America CorporationBoost Price TargetBuy$175.00 -> $195.00LowView Rating Details
3/19/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
2/27/2017Evercore ISIUpgradeHold -> Buy$190.00N/AView Rating Details
1/12/2017Robert W. BairdReiterated RatingNeutral$147.00 -> $153.00N/AView Rating Details
1/6/2017Janney Montgomery ScottReiterated RatingNeutral -> Sell$125.00N/AView Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyN/AView Rating Details
10/12/2016Wells Fargo & CompanyReiterated RatingMarket Perform$150.00 -> $137.50N/AView Rating Details
10/11/2016Citigroup Inc.DowngradeBuy -> Neutral$190.00 -> $140.00N/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00N/AView Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00N/AView Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00N/AView Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00N/AView Rating Details
3/23/2016Goldman Sachs Group, Inc. (The)Lower Price Target$141.00N/AView Rating Details
10/21/2015WedbushBoost Price TargetOutperform$150.00 -> $160.00N/AView Rating Details
10/8/2015William BlairReiterated RatingBuyN/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Illumina (NASDAQ:ILMN)
Earnings by Quarter for Illumina (NASDAQ:ILMN)
Earnings History by Quarter for Illumina (NASDAQ ILMN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2017Q2 2017$0.68$0.82$642.38 million$662.00 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Illumina (NASDAQ:ILMN)
2017 EPS Consensus Estimate: $3.58
2018 EPS Consensus Estimate: $4.42
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.63$0.82$0.69
Q2 20173$0.65$0.85$0.72
Q3 20173$0.99$1.06$1.02
Q4 20173$1.09$1.19$1.15
Q1 20183$0.93$1.02$0.99
Q2 20183$1.01$1.14$1.06
Q3 20182$1.17$1.18$1.18
Q4 20182$1.14$1.26$1.20
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Illumina (NASDAQ:ILMN)
Insider Ownership Percentage: 1.60%
Institutional Ownership Percentage: 93.32%
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/12/2017Jay T FlatleyDirectorSell20,000$211.11$4,222,200.00View SEC Filing  
9/12/2017Oene Mark VanSVPSell9,729$211.33$2,056,029.57View SEC Filing  
9/7/2017Mostafa RonaghiSVPSell20,000$210.00$4,200,000.00View SEC Filing  
9/5/2017Charles DadswellSVPSell145$205.71$29,827.95View SEC Filing  
9/5/2017Marc StapleyEVPSell2,000$205.93$411,860.00View SEC Filing  
8/31/2017Michel BouchardInsiderSell5,390$202.11$1,089,372.90View SEC Filing  
8/30/2017Michel BouchardCAOSell616$200.00$123,200.00View SEC Filing  
8/29/2017Jay T FlatleyDirectorSell22,540$195.21$4,400,033.40View SEC Filing  
8/28/2017Jay T FlatleyDirectorSell2,540$197.39$501,370.60View SEC Filing  
8/15/2017Jay T FlatleyDirectorSell20,000$194.73$3,894,600.00View SEC Filing  
8/7/2017Omead OstadanEVPSell1,671$195.26$326,279.46View SEC Filing  
8/3/2017Charles DadswellSVPSell1,609$197.00$316,973.00View SEC Filing  
8/3/2017Marc StapleyEVPSell2,000$196.80$393,600.00View SEC Filing  
8/2/2017Jay T FlatleyDirectorSell20,000$176.43$3,528,600.00View SEC Filing  
8/2/2017Michel BouchardInsiderSell3,131$194.97$610,451.07View SEC Filing  
8/2/2017Mostafa RonaghiSVPSell10,000$195.00$1,950,000.00View SEC Filing  
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.00View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.56View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.80View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.00View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.00View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.86View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.75View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.25View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.00View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.20View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.63View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.00View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.00View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.00View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.00View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.00View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.00View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.72View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.10View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.68View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.00View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.00View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.00View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.00View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.00View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.00View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.00View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.08View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.00View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.90View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.00View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.00View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.00View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.00View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.00View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.00View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.00View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.24View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.00View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.90View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.00View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.00View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.93View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.44View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.00View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.86View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.41View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.00View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.00View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.00View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.00View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.00View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.87View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.42View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.05View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.00View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.00View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.00View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.72View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.66View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.44View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.00View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.00View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.00View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.84View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.00View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.84View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.50View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.00View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.30View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.00View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.00View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.00View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.00View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.00View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.00View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.40View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.00View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.00View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.00View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.00View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.00View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.00View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.68View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.00View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.00View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.00View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.00View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.60View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.00View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.00View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.00View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.00View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.00View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.70View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.00View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.28View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.14View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.65View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.00View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.00View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.16View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.00View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.00View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.00View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.00View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.00View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.00View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Illumina (NASDAQ:ILMN)
Latest Headlines for Illumina (NASDAQ:ILMN)
Source:
DateHeadline
americanbankingnews.com logoIllumina, Inc. (ILMN) Stock Rating Upgraded by Vetr Inc.
www.americanbankingnews.com - September 20 at 12:46 AM
finance.yahoo.com logo3 Innovation-Forward Healthcare Stocks to Buy Now
finance.yahoo.com - September 19 at 7:54 PM
finance.yahoo.com logoETFs with exposure to Illumina, Inc. : September 14, 2017
finance.yahoo.com - September 15 at 12:29 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Director Sells $4,222,200.00 in Stock
www.americanbankingnews.com - September 14 at 10:34 PM
americanbankingnews.com logoInsider Selling: Illumina, Inc. (ILMN) SVP Sells 9,729 Shares of Stock
www.americanbankingnews.com - September 14 at 10:32 PM
americanbankingnews.com logoQ3 2017 Earnings Forecast for Illumina, Inc. (ILMN) Issued By Leerink Swann
www.americanbankingnews.com - September 14 at 6:56 AM
finance.yahoo.com logoIllumina, Inc. :ILMN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
finance.yahoo.com - September 14 at 6:24 AM
americanbankingnews.com logoArgus Raises Illumina, Inc. (ILMN) Price Target to $235.00
www.americanbankingnews.com - September 13 at 2:22 PM
americanbankingnews.com logoLeerink Swann Comments on Illumina, Inc.'s Q4 2017 Earnings (ILMN)
www.americanbankingnews.com - September 13 at 9:02 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Upgraded at Leerink Swann
www.americanbankingnews.com - September 12 at 9:30 AM
americanbankingnews.com logo$692.05 Million in Sales Expected for Illumina, Inc. (ILMN) This Quarter
www.americanbankingnews.com - September 9 at 1:48 AM
americanbankingnews.com logoMostafa Ronaghi Sells 20,000 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - September 8 at 7:32 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) SVP Sells $29,827.95 in Stock
www.americanbankingnews.com - September 7 at 10:24 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) EVP Sells $411,860.00 in Stock
www.americanbankingnews.com - September 7 at 10:23 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Expected to Announce Earnings of $0.98 Per Share
www.americanbankingnews.com - September 7 at 10:20 PM
fool.com logoWhy Illumina Rose 18.7% in August
www.fool.com - September 7 at 12:29 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) CAO Sells $123,200.00 in Stock
www.americanbankingnews.com - September 1 at 8:30 PM
bizjournals.com logoTechnical Insights on Biotech Stocks -- Grifols, Halozyme Therapeutics, Illumina, and VIVUS
www.bizjournals.com - September 1 at 8:11 PM
americanbankingnews.com logoInsider Selling: Illumina, Inc. (ILMN) Insider Sells 5,390 Shares of Stock
www.americanbankingnews.com - September 1 at 7:20 PM
americanbankingnews.com logoWilliam Blair Comments on Illumina, Inc.'s Q3 2017 Earnings (ILMN)
www.americanbankingnews.com - September 1 at 6:56 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Director Jay T. Flatley Sells 2,540 Shares
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoJay T. Flatley Sells 22,540 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - August 30 at 10:20 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 30 at 4:44 PM
finance.yahoo.com logoIllumina and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of Next-Generation Sequencing in the Global Forensic Genomics Market
finance.yahoo.com - August 25 at 7:00 AM
investopedia.com logoWhy Big Investors Are Betting on Illumina
www.investopedia.com - August 23 at 1:18 AM
americanbankingnews.com logoIllumina, Inc. (ILMN) Rating Lowered to Sell at BidaskClub
www.americanbankingnews.com - August 20 at 12:10 PM
americanbankingnews.com logoZacks: Analysts Expect Illumina, Inc. (ILMN) to Post $1.00 EPS
www.americanbankingnews.com - August 20 at 8:56 AM
marketwatch.com logoThese 5 underloved stocks deserve your attention
www.marketwatch.com - August 18 at 7:39 PM
americanbankingnews.com logoJay T. Flatley Sells 20,000 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - August 17 at 10:26 PM
americanbankingnews.com logoIllumina, Inc. Expected to Earn FY2017 Earnings of $3.62 Per Share (ILMN)
www.americanbankingnews.com - August 17 at 9:00 AM
marketwatch.com logoOpinion: 5 underloved stocks worth your attention - MarketWatch
www.marketwatch.com - August 17 at 5:50 AM
finance.yahoo.com logo5 underloved stocks worth your attention
finance.yahoo.com - August 17 at 5:50 AM
americanbankingnews.com logoIllumina, Inc. Forecasted to Post FY2018 Earnings of $4.36 Per Share (ILMN)
www.americanbankingnews.com - August 16 at 1:32 PM
finanznachrichten.de logoPro-Trader Daily: Earnings Review and Free Research Report: Illumina Reported Better Than Expected Revenue and Earnings Results
www.finanznachrichten.de - August 16 at 1:07 AM
finance.yahoo.com logoEarnings Review and Free Research Report: Illumina Reported Better Than Expected Revenue and Earnings Results
finance.yahoo.com - August 16 at 1:07 AM
finance.yahoo.com logoOne Company That's Set to Win From Precision Medicine
finance.yahoo.com - August 16 at 1:07 AM
americanbankingnews.com logoComparing Dextera Surgical (DXTR) & Illumina (ILMN)
www.americanbankingnews.com - August 15 at 10:28 PM
fool.com logoOne Company That's Set to Win From Precision Medicine
www.fool.com - August 15 at 6:02 PM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Illumina Inc.
finance.yahoo.com - August 14 at 10:22 PM
finance.yahoo.com logoThe Best Marijuana and Precision Medicine Stocks to Buy Might Not Be the Companies You Think
finance.yahoo.com - August 14 at 10:22 PM
finance.yahoo.com logoIHS Markit Score downgrades Illumina Inc to 32 out of 100, ranking positively in only one out of three available IHS Markit categories.
finance.yahoo.com - August 11 at 11:06 PM
finance.yahoo.com logoAzumio Introduces DNA-Based Insights into its Fitness Platform
finance.yahoo.com - August 10 at 1:06 AM
americanbankingnews.com logoInsider Selling: Illumina, Inc. (NASDAQ:ILMN) EVP Sells 1,671 Shares of Stock
www.americanbankingnews.com - August 9 at 10:20 PM
fool.com logoIllumina Introduces a New Genomic Era
www.fool.com - August 9 at 8:15 AM
finance.yahoo.com logoIllumina, Inc. – Value Analysis (NASDAQ:ILMN) : August 8, 2017
finance.yahoo.com - August 8 at 7:30 PM
americanbankingnews.com logoIllumina, Inc. (ILMN) SVP Sells $316,973.00 in Stock
www.americanbankingnews.com - August 7 at 10:32 PM
americanbankingnews.com logoIllumina, Inc. (NASDAQ:ILMN) EVP Marc Stapley Sells 2,000 Shares
www.americanbankingnews.com - August 7 at 10:32 PM
finance.yahoo.com logoIllumina Now A Buy Following Q2 Beat, Improved Sales Outlook
finance.yahoo.com - August 7 at 7:16 PM
fool.com logoIs Illumina Stock a Buy at Nearly 40 Times Earnings? 1 Analyst Thinks So
www.fool.com - August 7 at 12:50 PM
americanbankingnews.com logoCanaccord Genuity Upgrades Illumina, Inc. (ILMN) to Buy
www.americanbankingnews.com - August 7 at 8:00 AM

Social

Chart

Illumina (ILMN) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff